FdaApplication
ANDA 206936
Identifiers
- fda_app_no: ANDA206936
Properties
| Property | Value |
|---|---|
| applicant_name | MYLAN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2017-10-03 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLATIRAMER ACETATE | GLATIRAMER ACETATE | 40MG/ML | INJECTABLE;SUBCUTANEOUS |
1 product